AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

Abstract

Highlights Cervical dystonia has significant impact on quality of life of those affected. Dilution options allow for treatment flexibility and individualized patient care. AboBoNT-A is efficacious with similar safety and tolerability at either dilution.